Atlas Trials

Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA

Clinical trial NCT03926260 · COMPLETED

Trial details

NCT number
NCT03926260
Sponsor
Centre Hospitalier Departemental Vendee
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Non-small Cell Lung Cancer
Start date
2019-06-27
Primary completion
2021-07-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.